Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001493152-25-021980
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Global Innovative Platforms GIPL public float $3M, Sep 30, 2025
- ENDRA Life Sciences NDRA public float $3M, Jun 30, 2025
- Bluejay Diagnostics BJDX public float $3M, Jun 30, 2025
- Stimcell Energetics STME public float $2M, Nov 30, 2025
- LogicMark LGMK public float $2M, Jun 30, 2025
